catalpol has been researched along with Sepsis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Qiang, Y; Zhang, M | 1 |
| Cheng, F; Feng, S; Hu, W; Jiang, Y; Liu, Y; Pu, Y; Wu, T; Wu, Z; Yang, W; Yu, N; Zhang, J; Zhu, H; Zou, L | 1 |
2 other study(ies) available for catalpol and Sepsis
| Article | Year |
|---|---|
Catalpol ameliorates inflammation and oxidative stress via regulating Sirt1 and activating Nrf2/HO-1 signaling against acute kidney injury.
Topics: Acute Kidney Injury; Animals; Inflammation; Interleukin-6; Lipopolysaccharides; Mice; NF-E2-Related Factor 2; Oxidative Stress; Sepsis; Sirtuin 1; Tumor Necrosis Factor-alpha | 2023 |
Catalpol rescues LPS-induced cognitive impairment via inhibition of NF-Κb-regulated neuroinflammation and up-regulation of TrkB-mediated BDNF secretion in mice.
Topics: Animals; Brain-Derived Neurotrophic Factor; Chromatography, Liquid; Cognitive Dysfunction; Lipopolysaccharides; Mice; Molecular Docking Simulation; Neuroinflammatory Diseases; NF-kappa B; Rats; Sepsis; Tandem Mass Spectrometry; Up-Regulation | 2024 |